NovoCure (NVCR) News Today $26.17 +0.15 (+0.58%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period FY2024 EPS Estimates for NovoCure Raised by HC WainwrightJanuary 19 at 2:13 AM | americanbankingnews.comHC Wainwright Predicts NovoCure FY2029 EarningsJanuary 18 at 3:25 AM | americanbankingnews.comWedbush Forecasts NovoCure's FY2024 Earnings (NASDAQ:NVCR)January 18 at 2:07 AM | americanbankingnews.comHC Wainwright Analysts Boost Earnings Estimates for NovoCureNovoCure Limited (NASDAQ:NVCR - Free Report) - Research analysts at HC Wainwright boosted their FY2024 EPS estimates for NovoCure in a research note issued to investors on Tuesday, January 14th. HC Wainwright analyst E. Bodnar now expects that the medical equipment provider will post earnings ofJanuary 17 at 6:40 AM | marketbeat.comHC Wainwright Estimates NovoCure FY2029 EarningsNovoCure Limited (NASDAQ:NVCR - Free Report) - Equities researchers at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for NovoCure in a research note issued on Tuesday, January 14th. HC Wainwright analyst E. Bodnar anticipates that the medical equipment provider will post eaJanuary 16, 2025 | marketbeat.comWhat is Wedbush's Estimate for NovoCure FY2024 Earnings?NovoCure Limited (NASDAQ:NVCR - Free Report) - Wedbush increased their FY2024 earnings per share estimates for NovoCure in a research note issued to investors on Monday, January 13th. Wedbush analyst D. Nierengarten now anticipates that the medical equipment provider will post earnings per shareJanuary 16, 2025 | marketbeat.comNovoCure’s Strong Revenue Growth and Strategic Advancements Support Buy RatingJanuary 14, 2025 | markets.businessinsider.comDeep Dive Into NovoCure Stock: Analyst Perspectives (7 Ratings)January 14, 2025 | benzinga.comNovoCure (NASDAQ:NVCR) Earns "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $38.00 target price on shares of NovoCure in a report on Tuesday.January 14, 2025 | marketbeat.comNovocure sees FY24 revenue $605.2M, consensus $596.95MJanuary 14, 2025 | markets.businessinsider.comNovoCure’s Strong U.S. Revenue and European Growth Reinforce Buy Rating Despite Mixed Regional PerformanceJanuary 14, 2025 | markets.businessinsider.comNovoCure's (NVCR) Neutral Rating Reiterated at WedbushWedbush reaffirmed a "neutral" rating and issued a $29.00 price objective on shares of NovoCure in a report on Monday.January 13, 2025 | marketbeat.comNovocure anticipates higher-than-expected 2024 revenuesJanuary 13, 2025 | msn.comNovocure Announces Preliminary Full Year and Fourth Quarter 2024 Performance and Provides Company UpdateJanuary 13, 2025 | finance.yahoo.comNovoCure Limited (NASDAQ:NVCR) Receives Average Recommendation of "Moderate Buy" from BrokeragesShares of NovoCure Limited (NASDAQ:NVCR - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six ratings firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendatJanuary 5, 2025 | marketbeat.comNovocure to Participate in 43rd Annual J.P. Morgan Healthcare ConferenceJanuary 3, 2025 | businesswire.comNovocure price target raised to $46 from $34 at Evercore ISIJanuary 2, 2025 | markets.businessinsider.comNovocure Limited Share Price (NVCR.US)January 2, 2025 | lse.co.ukNovocure Limited Share Price (NVCR.US)January 2, 2025 | lse.co.ukNovoCure Limited (NASDAQ:NVCR) Shares Acquired by Franklin Resources Inc.Franklin Resources Inc. boosted its stake in NovoCure Limited (NASDAQ:NVCR - Free Report) by 222.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 180,853 shares of the medical equipment proviDecember 26, 2024 | marketbeat.comGeode Capital Management LLC Acquires 29,871 Shares of NovoCure Limited (NASDAQ:NVCR)Geode Capital Management LLC boosted its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 1.3% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,405,257 shares of the medical equipment provider's stock afteDecember 25, 2024 | marketbeat.comNovoCure (NASDAQ:NVCR) Sets New 52-Week High - Should You Buy?NovoCure (NASDAQ:NVCR) Sets New 12-Month High - Time to Buy?December 18, 2024 | marketbeat.comNovoCure (NASDAQ:NVCR) Shares Gap Up After Analyst UpgradeNovoCure (NASDAQ:NVCR) Shares Gap Up After Analyst UpgradeDecember 13, 2024 | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for NovoCure (NASDAQ:NVCR) StockPiper Sandler increased their price target on NovoCure from $28.00 to $42.00 and gave the company an "overweight" rating in a research report on Friday.December 13, 2024 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of NovoCure Limited (NASDAQ:NVCR - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six analysts that are presently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating oDecember 11, 2024 | marketbeat.com47,034 Shares in NovoCure Limited (NASDAQ:NVCR) Acquired by Weiss Asset Management LPWeiss Asset Management LP purchased a new stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 47,034 shares of the medical equipment provider's stock, valued at approximately $735December 9, 2024 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP lowered its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 26.9% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 963,900 shares of the medical equipment provider's stock after sellingDecember 9, 2024 | marketbeat.comQuantinno Capital Management LP Cuts Position in NovoCure Limited (NASDAQ:NVCR)Quantinno Capital Management LP cut its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 29.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 251,531 shares of the medical eqDecember 9, 2024 | marketbeat.comHolocene Advisors LP Purchases 22,276 Shares of NovoCure Limited (NASDAQ:NVCR)Holocene Advisors LP lifted its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 42.9% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 74,248 shares of the medical equipment provDecember 7, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Stake in NovoCure Limited (NASDAQ:NVCR)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in NovoCure Limited (NASDAQ:NVCR - Free Report) by 10.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 907,December 7, 2024 | marketbeat.comMetLife Investment Management LLC Increases Stock Holdings in NovoCure Limited (NASDAQ:NVCR)MetLife Investment Management LLC increased its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 129.1% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,603 shares of the medical equipment providDecember 7, 2024 | marketbeat.comNovoCure (NASDAQ:NVCR) Shares Gap Up - Time to Buy?NovoCure (NASDAQ:NVCR) Shares Gap Up - Still a Buy?December 6, 2024 | marketbeat.comWhy NovoCure Stock Was Winning Big This WeekDecember 6, 2024 | fool.comBNP Paribas Financial Markets Has $2.75 Million Stock Position in NovoCure Limited (NASDAQ:NVCR)BNP Paribas Financial Markets reduced its stake in NovoCure Limited (NASDAQ:NVCR - Free Report) by 24.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 175,926 shares of the medical equipment provider's stDecember 6, 2024 | marketbeat.comNovocure Has Already Doubled in 2024. Can It Soar Higher in 2025?December 5, 2024 | fool.comNovoCure: PANOVA-3 Data Suggests A Potential Game-Changer For Pancreatic CancerDecember 4, 2024 | seekingalpha.comPositive Outlook for NovoCure: Buy Rating Backed by Successful PANOVA-3 Trial and Promising Market PotentialDecember 4, 2024 | markets.businessinsider.com115,929 Shares in NovoCure Limited (NASDAQ:NVCR) Purchased by Edgestream Partners L.P.Edgestream Partners L.P. purchased a new stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 115,929 shares of the medical equipment provider's stock, valued at approximDecember 4, 2024 | marketbeat.com22,143 Shares in NovoCure Limited (NASDAQ:NVCR) Bought by Intech Investment Management LLCIntech Investment Management LLC purchased a new stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 22,143 shares of the medical equipmeDecember 4, 2024 | marketbeat.comNovocure seeks approval after pancreatic cancer wearable scores at Phase IIIDecember 4, 2024 | msn.comBridgewater Associates LP Sells 41,898 Shares of NovoCure Limited (NASDAQ:NVCR)Bridgewater Associates LP lowered its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 51.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 39,383 shares of the medical equipment provider's stock after selling 41,898 shareDecember 3, 2024 | marketbeat.comNovoCure’s PANOVA-3 Trial Success Boosts Oncology ProspectsDecember 3, 2024 | markets.businessinsider.comNovocure Stock Soars On Positive Pancreatic Cancer Trial Results, Retail Sentiment SurgesDecember 2, 2024 | msn.comNovocure Moves Pancreatic Cancer Treatment Forward With A 'First' Using TTFieldsDecember 2, 2024 | seekingalpha.comZai Lab, Novocure Report Positive Topline Results From Phase 3 PANOVA-3 Trial Of TTFields TherapyDecember 2, 2024 | markets.businessinsider.comNovocure Announces Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic CancerDecember 2, 2024 | stockhouse.comNavigating 5 Analyst Ratings For NovoCureDecember 2, 2024 | benzinga.comNovocure therapy succeeds in pancreatic cancer trialDecember 2, 2024 | msn.comNovocure's Stock Skyrockets Over 32% Amid Groundbreaking Pancreatic Cancer Therapy SuccessDecember 2, 2024 | finance.yahoo.comNovocure's pancreatic cancer treatment meets main goal in late-stage studyDecember 2, 2024 | reuters.com Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCR Media Mentions By Week NVCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCR News Sentiment▼0.670.44▲Average Medical News Sentiment NVCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCR Articles This Week▼235▲NVCR Articles Average Week Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Smith & Nephew News Penumbra News Glaukos News Bausch + Lomb News Inspire Medical Systems News Inari Medical News PROCEPT BioRobotics News Envista News iRhythm Technologies News LivaNova News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCR) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump secret stock already up 339% In this video, you’ll also get nine other Trump-connected investments… All of which we believe could have a...Porter & Company | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVCR Stock Alerts